Matches in Wikidata for { <http://www.wikidata.org/entity/Q90359465> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q90359465 description "article scientifique publié en 2018" @default.
- Q90359465 description "artículu científicu espublizáu en xunu de 2018" @default.
- Q90359465 description "scientific article published on 01 June 2018" @default.
- Q90359465 description "wetenschappelijk artikel" @default.
- Q90359465 description "наукова стаття, опублікована в червні 2018" @default.
- Q90359465 name "Phase 1b open-label study evaluating the safety, pharmacokinetics, and preliminary efficacy of ABT-165 plus FOLFIRI in patients with second-line (2L) colorectal cancer (CRC)" @default.
- Q90359465 name "Phase 1b open-label study evaluating the safety, pharmacokinetics, and preliminary efficacy of ABT-165 plus FOLFIRI in patients with second-line (2L) colorectal cancer (CRC)" @default.
- Q90359465 type Item @default.
- Q90359465 label "Phase 1b open-label study evaluating the safety, pharmacokinetics, and preliminary efficacy of ABT-165 plus FOLFIRI in patients with second-line (2L) colorectal cancer (CRC)" @default.
- Q90359465 label "Phase 1b open-label study evaluating the safety, pharmacokinetics, and preliminary efficacy of ABT-165 plus FOLFIRI in patients with second-line (2L) colorectal cancer (CRC)" @default.
- Q90359465 prefLabel "Phase 1b open-label study evaluating the safety, pharmacokinetics, and preliminary efficacy of ABT-165 plus FOLFIRI in patients with second-line (2L) colorectal cancer (CRC)" @default.
- Q90359465 prefLabel "Phase 1b open-label study evaluating the safety, pharmacokinetics, and preliminary efficacy of ABT-165 plus FOLFIRI in patients with second-line (2L) colorectal cancer (CRC)" @default.
- Q90359465 P1433 Q90359465-4C5D5CA2-0A98-418C-BE5B-3D3AE1D0A498 @default.
- Q90359465 P1476 Q90359465-07869AD5-3BD3-4BF6-9D58-31D46B96C279 @default.
- Q90359465 P2093 Q90359465-017B8C23-6B8F-42EE-91A0-C8B634266853 @default.
- Q90359465 P2093 Q90359465-241BD866-2488-4840-8502-A44287884961 @default.
- Q90359465 P2093 Q90359465-2AAD7451-CDF5-4DD9-B464-635582B9E35B @default.
- Q90359465 P2093 Q90359465-43376880-2671-45C9-9D66-967B8C600DE7 @default.
- Q90359465 P2093 Q90359465-67DA15AA-4F25-4C16-8409-F1D0DC250329 @default.
- Q90359465 P2093 Q90359465-6D163131-9F1E-4C8E-AFA9-7DE7B43DAF9D @default.
- Q90359465 P2093 Q90359465-70276AB7-0367-47F1-99BB-A02EF2AFAB04 @default.
- Q90359465 P2093 Q90359465-D9758B95-5CB4-4353-A7E9-D17E83596989 @default.
- Q90359465 P2093 Q90359465-F0BEA975-B59A-4FD3-8683-B39DCF343C43 @default.
- Q90359465 P2093 Q90359465-F69FD25B-B668-4DB2-85C8-6E9CBA386675 @default.
- Q90359465 P304 Q90359465-7E8D80D4-8741-4F0C-8A66-A45DB1EB9AA0 @default.
- Q90359465 P31 Q90359465-E0954313-024D-4CA7-85E6-817E2EB41EB2 @default.
- Q90359465 P356 Q90359465-B0D33535-40F5-460C-AD00-A2C8AA9C77C4 @default.
- Q90359465 P478 Q90359465-E2D93245-EA46-4CA5-831C-734675D069D4 @default.
- Q90359465 P577 Q90359465-7A12957D-D0CC-4C9A-9972-5AF9D66128E5 @default.
- Q90359465 P921 Q90359465-3F9BE7D1-7657-4230-9636-D3D24B68BF96 @default.
- Q90359465 P921 Q90359465-A796537E-0196-48B5-A1A7-BA61656807F7 @default.
- Q90359465 P356 MDY151.233 @default.
- Q90359465 P1433 Q326122 @default.
- Q90359465 P1476 "Phase 1b open-label study evaluating the safety, pharmacokinetics, and preliminary efficacy of ABT-165 plus FOLFIRI in patients with second-line (2L) colorectal cancer (CRC)" @default.
- Q90359465 P2093 "E Hamilton" @default.
- Q90359465 P2093 "H Yue" @default.
- Q90359465 P2093 "J Strickler" @default.
- Q90359465 P2093 "L Naumovski" @default.
- Q90359465 P2093 "L Wang" @default.
- Q90359465 P2093 "M Barve" @default.
- Q90359465 P2093 "M Gordon" @default.
- Q90359465 P2093 "M Motwani" @default.
- Q90359465 P2093 "S Kasichayanula" @default.
- Q90359465 P2093 "Z Wainberg" @default.
- Q90359465 P304 "v66" @default.
- Q90359465 P31 Q13442814 @default.
- Q90359465 P356 "10.1093/ANNONC/MDY151.233" @default.
- Q90359465 P478 "29 Suppl 5" @default.
- Q90359465 P577 "2018-06-01T00:00:00Z" @default.
- Q90359465 P921 Q188874 @default.
- Q90359465 P921 Q323936 @default.